Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole versus risperidone for schizophrenia
IRCT201305233930N26Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aripiprazole and risperidone in schizophrenia (2 arms), sponsored by Shiraz University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201305233930N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201305233930N26.